168 related articles for article (PubMed ID: 36522424)
1. CASZ1: a promising factor modulating aldosterone biosynthesis and mineralocorticoid receptor activity.
Yokota K; Shibata H; Kurihara I; Itoh H; Sone M
Hypertens Res; 2023 Feb; 46(2):417-420. PubMed ID: 36522424
[TBL] [Abstract][Full Text] [Related]
2. CASZ1b is a novel transcriptional corepressor of mineralocorticoid receptor.
Yokota K; Shibata H; Kurihara I; Kobayashi S; Murai-Takeda A; Itoh H
Hypertens Res; 2021 Apr; 44(4):407-416. PubMed ID: 33077905
[TBL] [Abstract][Full Text] [Related]
3. Identification of risk loci for primary aldosteronism in genome-wide association studies.
Le Floch E; Cosentino T; Larsen CK; Beuschlein F; Reincke M; Amar L; Rossi GP; De Sousa K; Baron S; Chantalat S; Saintpierre B; Lenzini L; Frouin A; Giscos-Douriez I; Ferey M; Abdellatif AB; Meatchi T; Empana JP; Jouven X; Gieger C; Waldenberger M; Peters A; Cusi D; Salvi E; Meneton P; Touvier M; Deschasaux M; Druesne-Pecollo N; Boulkroun S; Fernandes-Rosa FL; Deleuze JF; Jeunemaitre X; Zennaro MC
Nat Commun; 2022 Sep; 13(1):5198. PubMed ID: 36057693
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone and Mineralocorticoid Receptors-Physiology and Pathophysiology.
Funder JW
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492512
[TBL] [Abstract][Full Text] [Related]
5.
Jian H; Poetsch A
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509718
[TBL] [Abstract][Full Text] [Related]
6. CASZ1b, the short isoform of CASZ1 gene, coexpresses with CASZ1a during neurogenesis and suppresses neuroblastoma cell growth.
Liu Z; Naranjo A; Thiele CJ
PLoS One; 2011 Apr; 6(4):e18557. PubMed ID: 21490919
[TBL] [Abstract][Full Text] [Related]
7. The role of aldosterone and mineralocorticoid receptors in cardiovascular disease.
Funder JW
Am J Cardiovasc Drugs; 2007; 7(3):151-7. PubMed ID: 17610342
[TBL] [Abstract][Full Text] [Related]
8. Primary aldosteronism (PA) and endothelial progenitor cell (EPC) bioavailability.
Verhovez A; Zeoli A; Williams TA; Morello F; Brizzi MF; Veglio F; Mulatero P
Clin Endocrinol (Oxf); 2008 Oct; 69(4):528-34. PubMed ID: 18410543
[TBL] [Abstract][Full Text] [Related]
9. Zinc finger transcription factor CASZ1 interacts with histones, DNA repair proteins and recruits NuRD complex to regulate gene transcription.
Liu Z; Lam N; Thiele CJ
Oncotarget; 2015 Sep; 6(29):27628-40. PubMed ID: 26296975
[TBL] [Abstract][Full Text] [Related]
10. Renin Phenotypes Characterize Vascular Disease, Autonomous Aldosteronism, and Mineralocorticoid Receptor Activity.
Hundemer GL; Baudrand R; Brown JM; Curhan G; Williams GH; Vaidya A
J Clin Endocrinol Metab; 2017 Jun; 102(6):1835-1843. PubMed ID: 28323995
[TBL] [Abstract][Full Text] [Related]
11. Primary aldosteronism patients show skin alterations and abnormal activation of glucocorticoid receptor in keratinocytes.
Boix J; Bigas J; Sevilla LM; Iacobone M; Citton M; Torresan F; Caroccia B; Rossi GP; Pérez P
Sci Rep; 2017 Nov; 7(1):15806. PubMed ID: 29150654
[TBL] [Abstract][Full Text] [Related]
12. Mineralocorticoid receptor-associated hypertension and its organ damage: clinical relevance for resistant hypertension.
Shibata H; Itoh H
Am J Hypertens; 2012 May; 25(5):514-23. PubMed ID: 22258336
[TBL] [Abstract][Full Text] [Related]
13. Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1.
Amazit L; Le Billan F; Kolkhof P; Lamribet K; Viengchareun S; Fay MR; Khan JA; Hillisch A; Lombès M; Rafestin-Oblin ME; Fagart J
J Biol Chem; 2015 Sep; 290(36):21876-89. PubMed ID: 26203193
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of Aldosterone in Serum or Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
van der Gugten JG; Holmes DT
Methods Mol Biol; 2022; 2546():45-54. PubMed ID: 36127577
[TBL] [Abstract][Full Text] [Related]
15. Different polymorphisms of the mineralocorticoid receptor gene are associated with either glucocorticoid or mineralocorticoid levels in hypertension.
Sun B; Chamarthi B; Williams JS; Krug AW; Lasky-Su J; Raby BA; Hopkins PN; Jeunemaitre X; Ferri C; Williams GH
J Clin Endocrinol Metab; 2012 Sep; 97(9):E1825-9. PubMed ID: 22723323
[TBL] [Abstract][Full Text] [Related]
16. Endothelial progenitor cells in primary aldosteronism: a biomarker of severity for aldosterone vasculopathy and prognosis.
Wu VC; Lo SC; Chen YL; Huang PH; Tsai CT; Liang CJ; Kuo CC; Kuo YS; Lee BC; Wu EL; Lin YH; Sun YY; Lin SL; Chen JW; Lin SJ; Wu KD;
J Clin Endocrinol Metab; 2011 Oct; 96(10):3175-83. PubMed ID: 21816781
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiological mechanisms of mineralocorticoid receptor-dependent cardiovascular and chronic kidney disease.
Nishiyama A
Hypertens Res; 2019 Mar; 42(3):293-300. PubMed ID: 30523293
[TBL] [Abstract][Full Text] [Related]
18. Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.
Kawarazaki W; Fujita T
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):929-36. PubMed ID: 24111570
[TBL] [Abstract][Full Text] [Related]
19. Characterization of critical domains within the tumor suppressor CASZ1 required for transcriptional regulation and growth suppression.
Virden RA; Thiele CJ; Liu Z
Mol Cell Biol; 2012 Apr; 32(8):1518-28. PubMed ID: 22331471
[TBL] [Abstract][Full Text] [Related]
20. Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension.
Morimoto S; Ichihara A
Hypertens Res; 2020 Aug; 43(8):744-753. PubMed ID: 32424201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
